Tuesday, October 16, 2018

Startup developing HPV vaccine raises $2.75 million

PathoVax plans to initiate Phase 1 clinical trials for its HPV vaccine in the first half of 2020.



from https://www.bizjournals.com/baltimore/news/2018/10/16/startup-developing-hpv-vaccine-raises-2-75-million.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/179121327327
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)